http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Evaluation of Pulmonary Nodule in Mantle Cell Lymphoma
( Amar Ranjan ),( Harshita Dubey ),( Pranay Tanwar ) 대한결핵 및 호흡기학회 2020 대한결핵 및 호흡기학회 추계학술대회 초록집 Vol.128 No.0
Introduction Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin lymphoma (NHL) with median survival 3 -4 years from diagnosis. Method A case was retrieved from Hospital Record. Short Clinical History A 64 year old male presented with generalized lymphadenopathy. Hemogram showed TLC 12200/ cmm with 70% lymphoid cells in blood smear. Bone marrow (BM) aspirate smear showed 70% abnormal lymphoid cells, which was supported by biopsy (CD20+, CD3-). Viral markers were negative. Lymph node biopsy showed lymphoid cell positive for CD20, CD5 & Cyclin D and negative for CD3 & CD23; indicating MCL. Management with 6 # Bendamustine & Rutiximab resulted into clinical and hematological improvement. After 17 months of treatment free interval (TFI), he presented with Peripheral Neuropathy Grade -III, with no hematological or radiological abnormality. Pregabalin was advised. Again after 2 months (19 months of TFI) he presented with left inguinal lymphadenopathy. Biopsy from lymph node as well as BM showed abnormal lymphoid cells positive for CD20, CD5 & Cyclin D and negative for CD3, CD23, CD10 & BCL-6, MCL relapse was suggested. After 3 # CHOP type II Diabetes was detected. After 6 # CHOP chemotoxicity like fever, cough, vomiting, mucositis, oral ulcer etc. were noticed, which were managed conservatively along with Linalidomide and Prednisolone. Follow up x-ray & HRCT showed nodular lesions in right upper/ mid lobe; therapy for pulmonary Tuberculosis was started. Later he presented with painless and gradually increasing swelling in left thigh, for which radiotherapy showed partial relief. Doppler study for the cause of thigh swelling suggested a partial thrombus in left proximal Great saphanous vein, Lenalidomide induced Dddep vein thrombosis was considered, which was managed with anticoagulants. The case expired after some days. Conclusion Relapsed MCL cases are prone to develop Tuberculosis in developing countries leading to death.
A systematic review of clinical and laboratory parameters of 3,000 COVID-19 cases
( Harsh Goel ),( Ishan Gupta ),( Mbbs-student ),( Meenakshi Mourya ),( Sukhdeep Gill ),( Anita Chopra ),( Amar Ranjan ),( Goura Kishor Rath ),( Pranay Tanwar ) 대한산부인과학회 2021 Obstetrics & Gynecology Science Vol.64 No.2
The coronavirus disease 2019 (COVID-19) has spread worldwide. It is still a pandemic and poses major health problem across the globe. In our review, clinical characteristics and laboratory parameters of COVID-19 patients were compiled systematically, with special reference to pregnant women in order to understand the disease course. An extensive literature search on various scientific databases for relevant manuscripts was conducted, which yielded 7 manuscripts for final analysis. The most common symptoms were fever (85%), cough (70.63%), chest tightness (37.36%), expectoration (33.27%), fatigue (32%), dyspnea (31.95%), and shortness of breath (31.19%), while hemoptysis (1.0%) was the least common. The associated comorbidities were hypertension (21.6%) and diabetes (10.0%). In terms of hematological parameters, lower total leukocyte counts were observed in 65% of cases and biochemical parameters, patients demonstrated elevated levels of albumin (53.72%), lactate dehydrogenase (45.71%), and natriuretic peptide (34.84%); however, total bilirubin was elevated in only 8% of cases. In the acute inflammatory cytokine profile, C-reactive protein (59.0%), tumor necrosis factor (58.0%), erythrocyte sedimentation rate (57.0%), interleukin-2 (IL- 2, 54.0%), and IL-6 (52.0%) levels were increased, while prolactin levels (6.5%) were minimally elevated. The recovery rate was approximately 41%, and mortality was about 6.5%. The study also concluded that the clinical symptoms of COVID-19 were similar among pregnant and non-pregnant women. There was no evidence of vertical transmission of COVID-19 infection. This review critically analyzed COVID-19 as a public health hazard in order to help policy makers, health care givers, and primary physicians to promote early diagnosis and prevention.